FDA Modernization Act of 2021
This bill allows an applicant for market approval for a new drug to use methods other than animal testing to establish the drug's safety and effectiveness. Under this bill, these alternative methods may include cell-based assays, organ chips and microphysiological systems, sophisticated computer modeling, and other human biology-based test methods.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2021-04-16 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2021-04-15 | IntroReferral | Referred to the House Committee on Energy and Commerce. | House floor actions |
| 2021-04-15 | IntroReferral | Introduced in House | Library of Congress |